Ken Griffin Mei Pharma, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $0.35 $96 - $161	460 Added 793.1%	518 $0
Q4 2022 Feb 14, 2023	SELL	$0.22 - $8.4 $2,692 - $102,807	-12,239 Reduced 99.53%	58 $0
Q3 2022 Nov 14, 2022	SELL	$0.41 - $8.8 $20,988 - $450,489	-51,192 Reduced 80.63%	12,297 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $423,395 - $655,254	-1,008,084 Reduced 94.08%	63,489 $38,000
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $17,486 - $88,726	32,382 Added 3.12%	1,071,573 $646,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $87,128 - $126,017	-37,394 Reduced 3.47%	1,039,191 $2.77 Million
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $1.51 Million - $1.79 Million	-598,825 Reduced 35.74%	1,076,585 $2.97 Million
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $1.73 Million - $2.43 Million	-666,838 Reduced 28.47%	1,675,410 $4.77 Million
Q1 2021 May 17, 2021	SELL	$2.73 - $4.5 $59,770 - $98,523	-21,894 Reduced 0.93%	2,342,248 $8.03 Million
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $957,395 - $1.22 Million	-368,229 Reduced 13.48%	2,364,142 $6.24 Million
Q3 2020 Nov 16, 2020	SELL	$2.46 - $4.27 $113,359 - $196,765	-46,081 Reduced 1.66%	2,732,371 $8.53 Million
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $2.5 Million - $7.41 Million	1,723,267 Added 163.31%	2,778,452 $11.5 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.55 $746,066 - $2.54 Million	994,755 Added 1646.13%	1,055,185 $1.7 Million
Q2 2019 Aug 14, 2019	BUY	$2.45 - $3.32 $59,588 - $80,749	24,322 Added 67.36%	60,430 $151,000
Q3 2018 Nov 13, 2018	BUY	$3.39 - $4.61 $5,491 - $7,468	1,620 Added 4.7%	36,108 $0
Q2 2018 Aug 10, 2018	BUY	$1.89 - $4.95 $34,433 - $90,184	18,219 Added 111.99%	34,488 $0
Q4 2017 Feb 09, 2018	BUY	$1.91 - $2.83 $31,073 - $46,041	16,269	16,269 $34,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,557
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account